Atsena Therapeutics
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $122M
Investors
- 12
About Atsena Therapeutics
Founded in 2019 in Durham, North Carolina, Atsena Therapeutics specializes in gene therapy for retinal diseases. The company was established by Sanford Boye and Shannon Boye, with Patrick Ritschel serving as CEO.Atsena Therapeutics focuses on clinical-stage gene therapies that aim to address inherited retinal diseases, particularly those that can lead to blindness. Their primary therapies are currently in Phase I/II clinical trials, targeting conditions such as X-linked retinoschisis (XLRS) and GUCY2D-associated Leber congenital amaurosis (LCA1). Utilizing an adeno-associated virus (AAV) technology platform, these therapies deliver genetic material directly to retinal cells, striving to restore vision in affected patients.Atsena Therapeutics generates revenue through clinical partnerships and collaborations that support its gene therapy initiatives. Revenue is anticipated from partnerships with research institutions and healthcare entities involved in clinical trials, as well as potential milestone payments linked to the advancement of their therapies. The company may also pursue collaborative agreements with pharmaceutical companies to commercialize its therapies following successful trials. The company is focused on launching new gene therapies targeted at various inherited retinal diseases and expanding its market presence into North America and Europe by 2025.
Who invested in Atsena Therapeutics
12 investors across 3 rounds
See all investors in Atsena Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atsena Therapeutics
Who invested in Atsena Therapeutics?
Atsena Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atsena Therapeutics raised?
Atsena Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Atsena Therapeutics last raise money?
Atsena Therapeutics's most recent round on record is a Series C, in Mar 2025.
What does Atsena Therapeutics do?
Founded in 2019 in Durham, North Carolina, Atsena Therapeutics specializes in gene therapy for retinal diseases.
Where is Atsena Therapeutics headquartered?
Atsena Therapeutics is headquartered in Durham, US.
Which VCs invest in companies like Atsena Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Atsena Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Atsena Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.